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1108 Abstracts October 2014calf veins that previously were not visualized and seven were seen in
femoral veins or calf veins that previously were visualized and did not
have clot (Table).
Conclusions: Nonvisualized calf veins are common in DUS imag-
ing. Almost half of patients with nonvisualized veins on the initial DUS
imaging had successful visualization on subsequent DUS scans. Lower
body weight, whole leg swelling, single vein nonvisualization, and sin-
gle limb nonvisualization on the initial DUS scan were associated with
successful visualization on subsequent DUS scans. Of patients with
nonvisualized veins on the initial DUS scan, 4.8% go on to develop
VTE, and 8.8% of patients who have subsequent DUS scans are found
to have DVT. When the initial DUS scan is unable to visualize calf
veins, a repeat DUS scan may be useful to identify new or initially un-
seen DVT.Table. Factors associated with development of subsequent venous
thromboembolism (VTE) or successful calf vein visualization on
subsequent duplex ultrasound (DUS) scans after nonvisualization of calf
veins on the initial DUS scan
Factor
Development of
subsequent VTE
Successful
visualization of
calf veins on
subsequent DUS
P value,
c2 or t-testa
P value,
c2 or t-testa
Demographics
Gender 1.000 .187
Age .440 .726
Height .884 .861
Weight .580 .0497
Body mass index .532 .056
Well’s score criteria
Active malignancy .210 .125
Recent surgery or trauma .105 .832
Whole leg swelling .984 .025
Calf swelling 1.000 .058
Pitting Edema .513 1.000
Prior DVT 1.000 .578
Collateral superﬁcial vein 1.000 .453
Paralysis, cast or, immobilization .783 .344
Pain along deep veins .435 1.00
Alternative diagnosis .533 .650
Well’s score .833 .071
Initial DUS
Single or multiple
nonvisualized veins
.826 < .001
One or both lower extremities 1.000 .021
Reason for nonvisualization
Bandage .626 .294
Body habitus .502 .157
Wound 1.000 .453
Edema .822 .063
Multiple .610 1.000
Reason for DUS
Concern for PE .103 .042
Lower extremity swelling .132 .045
Abnormal laboratory values 1.000 .453
Pain .718 .448
Other 1.000 .546
Multiple .264 .184
Postimaging anticoagulation .410 1.000
DVT, Deep vein thrombosis; PE, Pulmonary embolism.
aP < .05 is statistically signiﬁcant.Author Disclosures: J. C. Henry: None; D. Strosberg: None; S.
Warhadpande: None; B. Satiani: None; M. R. Go: None.
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dergoing major vascular surgery. Prior studies suggest an association be-
tween blood transfusion and increased morbidity and mortality among
patients undergoing cardiac surgery. The effect of transfusion on patients
undergoing vascular surgery has been poorly deﬁned.
Methods: We examined data from a large multicenter quality
improvement vascular surgical registry of all patients undergoing elective
or urgent open peripheral arterial disease (PAD) procedures, endovascular
aneurysm repair (EVAR), or open abdominal aortic aneurysm (AAA)
repair between 2012 and 2013. Emergency cases, carotid endarterec-
tomy, and carotid artery stenting were excluded. Univariate and multivar-
iate logistic regression modeling was used to identify the effect of
transfusion on outcomes and predictors of transfusion. All regression
models had a Hosmer-Lemeshow P > .05 and area under receiver oper-
ating characteristic curve of >0.8, conﬁrming excellent goodness of ﬁt
and discrimination.
Results: Our study population comprised 2946 patients who un-
derwent open PAD procedures (n ¼ 1744), open AAA (n ¼ 175),
or EVAR (n ¼ 1027) at 22 hospitals. The overall transfusion rate
was 18%, at a median nadir hemoglobin of 7.7 g/dL. Adjusting for
major covariates, including preoperative anemia (hemoglobin <12 g/
dL), medications (including antiplatelets and anticoagulants), demo-
graphics, and comorbidities, transfusion was independently associated
with myocardial infarction (odds ratio [OR], 10.1; 95% conﬁdence in-
terval [CI], 5.2-19), death (OR, 3.8; 95% CI, 2.1-7), surgical site
infection (OR, 2.2; 95% CI, 1.3-3.5), and pneumonia (OR, 8.9; 95%
CI, 4.1-19). Independent factors predicting transfusion included female
gender (OR, 2.2; 95% CI, 1.7-2.7), body mass index (OR, 1.005; 95%
CI, 1.002-1.01), preoperative anemia (OR, 3.1; 95% CI, 2.4-3.8),
congestive heart failure (OR, 1.4; 95% CI, 1.1-1.9), clopidogrel (OR,
1.7; 95% CI, 1.3-2.2), open AAA repair (OR, 10.1; 95% CI, 6.5-
15.5), open bypass (OR, 3.1; 95% CI, 1.9-5.2), and urgent procedures
(OR, 1.4; 95% CI, 1.01-1.8).
Conclusions: Postoperative transfusion in vascular surgical patients is
independently associated with increased 30-day mortality and morbidity.
The risk of adverse cardiovascular events, including myocardial infarction,
was worsened rather than improved with transfusion. These data suggest
the need for a prospective comparative hemoglobin threshold study in
vascular surgical patients.
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Objectives: Current percutaneous vascular interventions to treat se-
vere atherosclerosis induce mechanical or thermal injury to the vessel
wall, which stimulates the development of neointimal hyperplasia and re-
sults in restenosis. The objective of this study was to develop a paradigm-
shifting methodology to reduce plaque burden without inducing trauma
to the arterial wall. We hypothesized that a digestion solution tailored to
the components of atherosclerotic plaques would effectively digest pla-
ques in situ.
Methods: After IRB approval, carotid plaques from endarterec-
tomies were collected, sectioned (200-mg segments), and exposed to
our digestion solution (10 mg/mL collagenase types I, III, IV, V,
and 10mM CaCl2) with ultrasonic sonication (20 kHz) at 42C, pH
7.2, for 20 minutes. Specimens were weighed at baseline and every
10 minutes. Superﬁcial femoral and popliteal arteries were harvested
from limb amputations and cut into 3-cm sections. The lumen was
exposed to our digestion solution or phosphate-buffered saline
(PBS), with or without ultrasonic sonication, for 1 hour or 20 mi-
nutes. Arterial segments were mounted in parafﬁn, sectioned, and
stained with hematoxylin and eosin, van Gieson, and Masson tri-
chrome. Plaque and medial area from ﬁve sections spaced 0.2 mm
apart were analyzed for each artery.
Results: First, we evaluated our optimized digestion solution
with sonication on the harvested human plaques. We found that our
therapy reduced plaque mass by 75% 6 6% at 15 minutes and by
86% 6 3% at 30 minutes vs PBS with sonication (12% 6 4% at 20 mi-
nutes; P < .05). Next, we evaluated the efﬁcacy of our digestion so-
lution on intact arteries. Our digestion solution with sonication
resulted in 92% reduction of the plaque area compared with PBS
with sonication at 1 hour (31%; P < .05). Medial area was constant
across all groups. Notably, the internal elastic lamina was intact after
